Thomas Land Publishers Names Leading Scientist Editor-in-Chief of HIV Clinical Trials
Posted on: Monday, 12 December 2005, 09:00 CST
Dr. Milos Opravil, a preeminent physician and researcher, has been named by Thomas Land Publishers as the Editor-in-Chief of the independent journal HIV Clinical Trials (HCT), effective January 1, 2006. Dr. Opravil will succeed Dr. Maurice Staquet, HCT's founding Editor-in-Chief, who will continue to serve on HCT's Editorial Board.
Dr. Opravil is Titular Professor of Infectious Diseases and Internal Medicine at the University of Zurich, Switzerland, and was a winner of the 1996 Pfizer Research Prize in Infectious Diseases. Dr. Opravil's research has included clinical studies involving pathogenesis and the treatment of HIV infection. He has been a member of the Scientific Board of the Swiss HIV Cohort Study since 1995. As Attending Physician at the University Hospital of Zurich, Dr. Opravil also works as a consultant for infectious diseases and supervises a large, outpatient infectious diseases clinic.
Since it was launched at the International AIDS Conference in Durban, South Africa in July 2000, HIV Clinical Trials has published the work of more than 1,000 leading researchers in HIV therapeutics. "HIV Clinical Trials has a unique pan-continental perspective," said Kenneth Killion, HCT Publisher. "As an unbiased and independent journal, HCT provides valuable, global access to late-breaking HIV data and includes reports of original HIV clinical trials. We are honored that Dr. Opravil will serve as our new Editor-in-Chief and we thank Dr. Staquet for his outstanding leadership in this role over the past six years."
About HIV Clinical Trials
HIV Clinical Trials, published by Thomas Land Publishers, is available in print and online. Major educational and research institutions, public health governmental bodies, and pharmaceutical firms make extensive use of HCT's online archive of all published articles. Thomas Land Publishers' journals also include Topics in Stroke Rehabilitation and Topics in Spinal Cord Injury Rehabilitation.
About Thomas Land Publishers, Inc.
Founded in 1998, Thomas Land Publishers is a privately owned company that specializes in rehabilitation and clinical medicine journals, books, and electronic media. Thomas Land publications are peer-reviewed and independent. As a leading knowledge partner for the health professions, Thomas Land Publishers is able to react quickly to changes in the field and respond to customers' needs.
Source: Business Wire
Related Articles
- Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki
- Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
- ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
- Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates
- Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months
- Japan Institute of Infectious Diseases Publishes Second Article On Ampligen As Avian Flu Vaccine Immune Enhancer
- Oscient Pharmaceuticals' FACTIVE Tablets Subject of Poster Presentations at European Congress of Clinical Microbiology and Infectious Diseases; Leading European Conference Draws Key Scientific and Pharmaceutical Decision Makers
- Covalent Group, Inc. Signs $2.2 Million Contract With New Sponsor to Conduct Clinical Trial in Patients With Cardiovascular Disease
- Clinical Data on FACTIVE(R) Tablets for ABS and AECB Presented at the 43rd Annual Meeting of the Infectious Diseases Society of America
 |
 |
User Comments (0)
RSS Feeds